Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Dec 15, 2005
Letter to Shareholders re Share Placement
Dec 02, 2005
Short Form Prospectus
Dec 02, 2005
Capital Raising Presentation November 2005
Dec 02, 2005
Appendix 3B
Dec 02, 2005
Neuren raises $6.4 million in share placement
Dec 02, 2005
Reinstatement to Official Quotation
Dec 01, 2005
Suspension from Official Quotation
Nov 29, 2005
Trading Halt
Nov 24, 2005
Neuren Agreement with Jackson Foundation for Phase 3
Nov 09, 2005
Neuren Senior Scientist inducted to US Institute of Medicine
1
2
3
4
5
6
Next
